UBS Maintains Neutral on American Well, Lowers Price Target to $9
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
UBS analyst Kevin Caliendo maintains American Well (NYSE:AMWL) with a Neutral and lowers the price target from $12 to $9.
UBS analyst Kevin Caliendo maintains American Well (NYSE:AMWL) with a Neutral and lowers the price target from $12 to $9.